semaglutide mice dose The dietary-induced obese (DIO) mouse: A robust platform for the development of anti-obesity pharmacotherapies Tiziana Life Sciences Announces Positive

Evaluation of claims: Velomi presents a measured approach, emphasising that results depend on lifestyle factors and that the product is a supplement, not a medicine

2026 Safety Reality Check FDA communications on compounded GLP-1 products are ongoing

In general, most short-term changes in body weight are due to changes in water weight, which can occur due to recent exercise as well as recent changes in fluid and sodium intake, dietary pattern, stress, bowel movement frequency, and more

Glutamate transporters alterations in the reorganizing dentate gyrus are associated with progressive seizure activity in chronic epileptic rats

Similarly, GLP1-RA exenatide once weekly for 26 weeks reduced brain response, as measured by functional magnetic resonance imaging (fMRI), to alcohol cues in the ventral tegmental area 19

One real-world evidence study found that patients receiving GLP-1 receptor agonists had a higher risk of ulcerative colitis compared to those on DPP-4 inhibitors (a different diabetes drug class)